NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Camping World Holdings, Inc. (“Camping World” or the “Company”) (NYSE: CWH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Camping World and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class a ...

Core Viewpoint - A class action lawsuit has been filed against Ramaco Resources, Inc. concerning allegations of securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - The lawsuit involves claims that Ramaco and certain officers and/or directors engaged in securities fraud [2]. - Investors have until March 31, 2026, to request to be appointed as Lead Plaintiff if they purchased Ramaco securities during the Class Period [2]. Group 2: Allegations and Impact - A report by Wolfpack Research accused Ramaco's Brook Mine of being a "hoax" and claimed that no actual mining activity occurred after its July groundbreaking [4]. - Following the allegations, Ramaco Resources' stock price dropped by $3.81 per share, or 9.57%, closing at $36.01 on October 23, 2025 [4].

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Picard Medical, Inc. (“Picard” or the “Company”) (NYSE: PMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.  The class action concerns whether Picard and certain of its off ...

Core Viewpoint - Pomerantz Law Firm is investigating potential securities fraud and unlawful business practices by Ashford Hospitality Trust, Inc. and its officers or directors [1] Group 1: Company Actions - On January 13, 2026, Ashford announced the extension of its Highland mortgage loan secured by 18 hotels [1] - To maintain liquidity while evaluating strategic alternatives, Ashford suspended preferred dividends for various series of preferred stock, including those declared for record holders as of December 31, 2025, payable on January 15, 2026 [1] Group 2: Market Reaction - Following the announcement, Ashford's stock price decreased by $0.35 per share, representing an 8.1% decline, closing at $3.97 per share on January 13, 2026 [1]

Core Viewpoint - Girard Sharp, LLP is investigating potential claims on behalf of investors affected by Inspired Healthcare Capital (IHC), which has faced legal issues and filed for Chapter 11 bankruptcy [1][2]. Group 1: Company Overview - Inspired Healthcare Capital (IHC) is a private equity firm that specializes in senior living housing and real estate investments [2]. - In August 2025, IHC halted investor distributions, leading to a lawsuit filed by Emerson Equity Bridge Fund I, LLC on September 24, 2025, alleging fraud, breach of contract, and negligence [2]. Group 2: Legal Proceedings - IHC filed for Chapter 11 bankruptcy on February 2, 2026, in the Northern District of Texas, amid allegations of selling high-risk investments without adequate transparency [2]. - Girard Sharp, LLP has a history of representing investors in class actions and complex litigation, including a notable $36.5 million securities settlement against Maxar Technologies [4]. Group 3: Contact Information - Investors who believe they may have been impacted by IHC's actions are encouraged to contact Girard Sharp for a free consultation via phone or email [2][3].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Teleflex Incorporated and its executives following the abrupt departure of CEO Liam Kelly, which led to a significant drop in the company's stock price [1][3]. Group 1: Company Developments - On January 8, 2026, Teleflex announced the immediate departure of Liam Kelly as Chairman, President, and CEO [3]. - Following this announcement, Teleflex's stock price decreased by $16.52 per share, representing a 13.06% decline, closing at $110.01 per share [3]. Group 2: Legal Investigation - Pomerantz LLP is representing investors in investigating claims against Teleflex regarding possible securities fraud or other unlawful business practices [1]. - Investors are encouraged to contact Pomerantz LLP for more information regarding the class action [2].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices by Inovio Pharmaceuticals and its officers/directors, following a significant stock price drop after FDA news regarding its drug application [1][4]. Group 1: FDA Announcement and Stock Impact - On December 29, 2025, the FDA accepted Inovio's Biologics License Application for INO-3107, a treatment for recurrent respiratory papillomatosis, but did not find sufficient information for accelerated approval [3]. - Inovio's stock price fell by $0.56, or 24.45%, closing at $1.73 per share on the same day [4]. Group 2: Legal Investigation - Pomerantz LLP is reaching out to investors of Inovio regarding claims of potential securities fraud and is encouraging them to contact the firm for further information [1].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Apogee Enterprises, Inc. and its officers or directors [1] Financial Performance - On January 7, 2025, Apogee reported third-quarter financial results for the 2026 fiscal year, with sales of $355.3 million, which fell short of the consensus estimate of $348.6 million [3] - The CEO attributed the disappointing results to "higher aluminum, restructuring and health insurance costs" [3] - Following the announcement, Apogee's stock price decreased by $5.18 per share, or 13.89%, closing at $32.11 per share on January 7, 2026 [3]

Core Viewpoint - A class action lawsuit has been filed against Fermi Inc. regarding allegations of securities fraud and unlawful business practices following a significant drop in share price after its IPO [2][4]. Group 1: Lawsuit Details - The class action lawsuit concerns whether Fermi and certain officers and/or directors engaged in securities fraud or other unlawful business practices [2]. - Investors have until March 6, 2026, to request to be appointed as Lead Plaintiff if they purchased Fermi securities related to its IPO [2]. Group 2: IPO and Subsequent Developments - Fermi completed its IPO on October 1, 2025, offering 32.5 million shares at a price of $21.00 per share [4]. - On December 12, 2025, Fermi announced the termination of a $150 million Advance in Aid of Construction Agreement for its Project Matador data center, which negatively impacted investor confidence and share price [4].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for alleged securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - The lawsuit involves allegations against Alexandria and certain officers and/or directors regarding securities fraud [2]. - Investors have until January 26, 2026, to request to be appointed as Lead Plaintiff if they purchased Alexandria securities during the Class Period [2]. Group 2: Financial Performance - On October 27, 2025, Alexandria reported disappointing financial results for Q3 2025, including a reduction in full-year 2025 funds from operations (FFO) guidance [4]. - The company cited lower occupancy rates, slower leasing activity, and a significant real estate impairment charge of $323.9 million, with $206 million related to its Long Island City property [4]. Group 3: Market Reaction - Following the announcement of the financial results, Alexandria's stock price dropped by $14.93 per share, or 19.17%, closing at $62.94 per share on October 28, 2025 [5].